Citi Downgrades Brilliance China to Neutral, Trims Target Price to HK$2.55

Stock News
Yesterday

Citi has issued a research report stating that after a management meeting with Brilliance China (01114) yesterday, it has downgraded the stock's rating from "Buy/High Risk" to "Neutral/High Risk."

The bank believes the current risk-reward profile for the stock is balanced and has slightly reduced its target price from HK$2.7 to HK$2.55. Key considerations include: (1) Low sales visibility for the Neue Klasse iX3, as the final pricing aligns with delayed deliveries (expected in November 2026), potentially allowing competitors to seize orders during the two-month window; (2) The current high proportion of fuel vehicle sales (over 90%) places sales pressure on Brilliance BMW from the second half of this year into next year; (3) The interim dividend is reasonable at HK$0.5 per share; (4) Despite anticipated declines in sales over the next two years, the bank expects Brilliance BMW's net profit margin to remain resilient, supported by ongoing cost reductions and a rising export share, which will underpin future dividend distributions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10